基于中心的日间护理概念改善化脓性汗腺炎患者预后并具有成本效益
德国化脓性汗腺炎患者中心门诊护理创新模式与标准护理的成本效益对比数据集。

基本信息
资源简介
基于中心的日间护理概念改善化脓性汗腺炎患者预后并具有成本效益
【数据集背景】
本数据集源站标题为《A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective》。配套论文《A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective》发表于 Journal of Dermatological Treatment(2023),DOI:10.1080/09546634.2023.2284105。项目资助方:Innovation section, Germany; Institutional grant to perform the clinical study. The project on which this publication is based was funded by the Innovation Committee of the Federal Joint Committee (Gemeinsamer Bundesausschuss), under the grant number 01NVF18008.。源站首次发布:2026-08-24。
【数据内容】
源站原始描述:Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting approximately 1% of the population. The patient journey through the German health care system leads to high disease burden and substantial treatment costs. The EsmAiL study showed that an innovative, interprofessional, multimodal care-concept reduces disease activity and burden of HS compared to standard care. This paper examines the costs of treating HS in Germany and compares them with those of the innovative care c…
【数据结构与技术规格】
文件数 7 个,合计 147.33 KB。Supplement_1_International Statistical Classification of Diseases.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,16.27 KB。Supplement_2_ATC_Medication_treatment_costs.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,15.14 KB。Supplement_3_Costs of the new care concept .docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,24.03 KB。数据集 DOI:10.6084/m9.figshare.24640109.v4。
【主题与分类】
源站学科分类:Medicine、Pharmacology、Biotechnology、Sociology、Biological Sciences not elsewhere classified、Cancer。主题标签:Hidradenitis suppurativa、treatment costs、innovative care concept、ambulatory care。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://tandf.figshare.com/articles/dataset/A_center-based_ambulatory_care_concept_for_hidradenitis_suppurativa_improves_patient_outcomes_and_is_also_cost-effectiveness/24640109
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective. Taylor & Francis. Heise, Marcus; Staubach, Petra; Nikolakis, Georgios; Schollenberger, Lukas; Mauch, Melanie; Burckhardt, Marion; et al
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective
- DOI:10.6084/m9.figshare.24640109.v4
- 发布日期:2026-08-24
- 文件数:7 个
- 文件总体积:147.33 KB
- 源站页面:https://tandf.figshare.com/articles/dataset/A_center-based_ambulatory_care_concept_for_hidradenitis_suppurativa_improves_patient_outcomes_and_is_also_cost-effectiveness/24640109
命令行下载
curl -L -o "Supplement_1_International Statistical Classification of Diseases.docx" "https://ndownloader.figshare.com/files/43304051"
curl -L -o "Supplement_2_ATC_Medication_treatment_costs.docx" "https://ndownloader.figshare.com/files/43304054"
curl -L -o "Supplement_3_Costs of the new care concept .docx" "https://ndownloader.figshare.com/files/43304057"
curl -L -o "Supplement_4_baseline_IG_CG.docx" "https://ndownloader.figshare.com/files/43304060"
curl -L -o "Supplement_5_Prescribed_Medication.docx" "https://ndownloader.figshare.com/files/43304063"
curl -L -o "Supplement_6_VAS_based_weighted_health_status .docx" "https://ndownloader.figshare.com/files/43304072"
curl -L -o "Supplement_7_Scenario analysis treated patients.docx" "https://ndownloader.figshare.com/files/43304075"
文件清单
Supplement_1_International Statistical Classification of Diseases.docx(16.27 KB)Supplement_2_ATC_Medication_treatment_costs.docx(15.14 KB)Supplement_3_Costs of the new care concept .docx(24.03 KB)Supplement_4_baseline_IG_CG.docx(22.08 KB)Supplement_5_Prescribed_Medication.docx(21.22 KB)Supplement_6_VAS_based_weighted_health_status .docx(24.05 KB)Supplement_7_Scenario analysis treated patients.docx(24.55 KB)
文件总体积 147.33 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting approximately 1% of the population. The patient journey through the German health care system leads to high disease burden and substantial treatment costs. The EsmAiL study showed that an innovative, interprofessional, multimodal care-concept reduces disease activity and burden of HS compared to standard care. This paper examines the costs of treating HS in Germany and compares them with those of the innovative care concept implemented in EsmAiL.
EsmAiL was a two-arm, multicenter, prospective randomized controlled trial including 553 adults with HS. The study was registered in the German Clinical Trials Registry (DRKS00022135). The control group (CG) remained in standard care, whereas the intervention group (IG) was referred to specialized so-called ‘acne-inversa-centres (AiZ)’ where patients were treated with a structured, interdisciplinary approach. The present paper analyses the treatment costs for a subpopulation based on health insurance cost data from the two largest German health insurers. Quality-Adjusted Life Years (QALY) was assessed based on Dermatology Life Quality Index (DLQI).
Total annual treatment costs per patient were €3,966.07 in standard care (n = 89) and €3,974.37 in the innovative care (n = 93). The costs per additional QALY amounted to €12,698.72 in the IG. Given the conventional and established threshold of €22,600 to €33,900 per QALY, the innovative treatment in AiZ proved to be cost-effective.
Treatment costs of HS are substantial and increase with disease severity. The new form of care is cost-effective and is expected to decrease costs in the long run.
A structured, multimodal form of care reduces costs in the treatment of Hidradenitis suppurativa compared to standard care.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.24640109.v4(source: https://tandf.figshare.com/articles/dataset/A_center-based_ambulatory_care_concept_for_hidradenitis_suppurativa_improves_patient_outcomes_and_is_also_cost-effectiveness/24640109)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




